Kolexia
Seneschal Julien
Dermatologie
Hôpital Saint-André
Bordeaux, France
421 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Vitiligo Eczéma atopique Dermatite Psoriasis Sclérodermie systémique Eczéma Sclérose Lupus érythémateux disséminé Inflammation

Industries

Lilly
51 collaboration(s)
Dernière en 2023
Abbvie
37 collaboration(s)
Dernière en 2023
Janssen
29 collaboration(s)
Dernière en 2023
Sanofi
25 collaboration(s)
Dernière en 2023

Dernières activités

ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation
Essai Clinique (CHU Nice)   15 mars 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema.
Journal of the European Academy of Dermatology and Venereology : JEADV   08 mars 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes.
Journal of the European Academy of Dermatology and Venereology : JEADV   08 mars 2024
A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE): A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Deucravacitinib (BMS-986165) in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
Essai Clinique (BMS)   06 mars 2024
PB-DEPIST: Screening for Adrenal Insufficiency During Dermocorticoid Reduction in Bullous Pemphigoid
Essai Clinique (CHU Bordeaux)   16 février 2024
MADULO: Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis: a Non-inferiority Randomized Trial
Essai Clinique (CHU Nantes)   29 janvier 2024
SCLERESO: Cohort of Patients With Systemic Sclerosis and Associated Biological Collection Within the Framework of the RESO Reference Centre for Rare Systemic Autoimmune Diseases
Essai Clinique (CHU Bordeaux)   18 janvier 2024
PSSIT: Phase II/III Double-blind Randomized Placebo-controlled Trial Assessing the Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk in Subjects With Specific Dysimmunity and Raynaud Phenomenon
Essai Clinique (CHU Bordeaux)   18 janvier 2024
Stigma in Vitiligo: associated factors and severity strata of the PUSH-D score.
The British journal of dermatology   17 janvier 2024
Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis.
Allergy   18 décembre 2023